Microbiome Insights provides microbiome testing and bioinformatic analysis and is described in the article as a rapidly growing, global leader in that space. The company is developing a personal health platform intended for monitoring chronic disease, with an initial focus on inflammatory bowel disease. Its platform aims to help practitioners assess responses to therapies and lifestyle changes by integrating testing with ongoing data collection and research. The product development includes practitioner-facing interfaces and educational components. Company leadership cites a fresh approach to change the game for microbiome testing, and the IBD-focused efforts are led by Nataša Jovic, MBA. Microbiome Insights is exploring commercialization through research collaborations, distribution, or joint commercialization efforts.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2018